Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation.
about
Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment ParallelsCardiomyopathy and response to enzyme replacement therapy in a male mouse model for Fabry diseaseAldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans.Association of aldosterone synthase polymorphism (CYP11B2 -344T>C) and genetic ancestry with atrial fibrillation and serum aldosterone in African Americans with heart failureRapid and MR-Independent IK1 Activation by Aldosterone during Ischemia-Reperfusion.Aldosterone down-regulates the slowly activated delayed rectifier potassium current in adult guinea pig cardiomyocytesAldosterone and cardiovascular disease: the heart of the matter.Genome-wide screening identifies a KCNIP1 copy number variant as a genetic predictor for atrial fibrillationEffect of spironolactone on patients with atrial fibrillation and structural heart disease.IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial.Predictors of Atrial Fibrillation Risk in Hypertrophic Cardiomyopathy.Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation.Atrial fibrillation: mechanisms, therapeutics, and future directions.The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.Mineralocorticoid receptors and the heart, multiple cell types and multiple mechanisms: a focus on the cardiomyocyte.Eplerenone: a review of its use in patients with chronic systolic heart failure and mild symptoms.Mineralocorticoid receptor and cardiac arrhythmia.Future drug discovery in renin-angiotensin-aldosterone system intervention.Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis.Aldosterone and aldosterone antagonists in cardiac disease: what is known, what is new.Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling.Chronic atrial ionic remodeling by aldosterone: potentiation of L-type Ca2+ channels and its arrhythmogenic significance.Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry.Tachycardia of atrial myocytes induces collagen expression in atrial fibroblasts through transforming growth factor β1.Relationship between -344T/C polymorphism in the aldosterone synthase gene and atrial fibrillation in patients with essential hypertension.Aldosterone promotes atrial fibrillation
P2860
Q28067128-8BB11A60-7FFD-4A56-B2F1-E525933DF632Q28730130-9F4EC439-6567-4BB7-8DB7-6C2912FFD6B7Q34122713-3B034380-A29C-43D0-83DF-EF5E06883124Q34923747-F55FECD4-3F4E-457C-BB8E-AD8DE6B25181Q35722993-3432EB6E-7249-4C6D-872F-45D67D9BFD73Q36342150-67E1900C-763A-456F-9760-80F199E3620BQ36494721-0D794B01-9CDF-4401-9959-08E671EAD996Q36542196-40A01EB8-679F-4A13-9049-EBE8BC48A202Q36742906-A16A0CA8-F745-4E01-A60A-021CD36A81D8Q37355944-888B89E5-E709-4236-98C3-E348C01DF578Q37469007-CCE9CB34-0185-4B7A-8DF0-F6CE839FDA83Q37496071-F51B18DB-6FDE-4520-8F69-7181686E016BQ37590158-5C238F5F-64E4-4708-B326-B56AC88C6BE0Q37622571-73E60DE1-8E94-4BD4-9146-BA5F3CF2BBABQ37846370-C9220FA5-1637-4943-B833-9BDBECB30687Q38119546-B2CAD342-ED00-469E-9355-4A5A1ACDF540Q38123754-296913E2-EF47-4DF2-8240-1821AFD731AFQ38124345-95FD01D8-4993-43EB-A008-DAAC68D13667Q38679303-FC11833D-B319-4125-9088-436C9C4B5FA5Q39164366-61CC05A4-E57B-4D26-A552-C4951DC4A2DDQ40170291-143F9F12-A3A6-452F-9A41-E3038ADE8547Q40362633-FFBABABB-D9ED-4A57-A309-8181B6AC589DQ47318642-F57BF47E-B1B0-4832-93FA-ABF708EFCCAEQ48353759-F2F761E3-9ED3-4485-B46D-627D219786B9Q52589130-1345F2A3-6EFF-4D38-A516-F0E2EC1E2206Q53285086-15815E1E-A5A6-4B8A-90F3-1B803A479D69Q54353741-A726D481-91CF-4FEA-839B-167E026D7A8BQ57298791-323F401A-62BE-4870-B1B3-4F20533BD54D
P2860
Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Increased expression of minera ...... model of atrial fibrillation.
@en
Increased expression of minera ...... model of atrial fibrillation.
@nl
type
label
Increased expression of minera ...... model of atrial fibrillation.
@en
Increased expression of minera ...... model of atrial fibrillation.
@nl
prefLabel
Increased expression of minera ...... model of atrial fibrillation.
@en
Increased expression of minera ...... model of atrial fibrillation.
@nl
P50
P1476
Increased expression of minera ...... model of atrial fibrillation.
@en
P2093
Chuen-Den Tseng
Jiunn-Lee Lin
P304
P356
10.1016/J.JACC.2009.09.045
P407
P50
P577
2010-02-01T00:00:00Z